MSAM
Moloney Securities Asset Management’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2K | Sell |
12,000
-2,400
| -17% | -$8.23K | 0.01% | 475 |
|
|
2025
Q1 | $32.1K | Sell |
14,400
-76,000
| -84% | -$169K | ﹤0.01% | 466 |
|
|
2024
Q4 | $265K | Buy |
+90,400
| New | +$265K | 0.04% | 368 |
|
|
2022
Q3 | – | Sell |
-15,800
| Closed | -$168K | – | 380 |
|
|
2022
Q2 | $168K | Buy |
+15,800
| New | +$168K | 0.04% | 341 |
|
|
2022
Q1 | – | Sell |
-13,100
| Closed | -$187K | – | 414 |
|
|
2021
Q4 | $187K | Sell |
13,100
-9,000
| -41% | -$128K | 0.03% | 411 |
|
|
2021
Q3 | $443K | Buy |
22,100
+11,200
| +103% | +$225K | 0.08% | 262 |
|
|
2021
Q2 | $240K | Sell |
10,900
-20,050
| -65% | -$441K | 0.04% | 360 |
|
|
2021
Q1 | $1.05M | Buy |
+30,950
| New | +$1.05M | 0.21% | 130 |
|